Allurion
a new clinical studies report weight loss i boosting long term | Allurion
Company
Deck Type
Sector
Industry
Deck date
June 2023
Slide
16 of 25
Related slides by other companies
NeuroBo Pharmaceuticals
Investor Presentation
December 2023
phase study to evaluate and safety | NeuroBo Pharmaceuticals
NeuroBo Pharmaceuticals
Investor Presentation
January 2024
phase study to evaluate and safety | NeuroBo Pharmaceuticals
Ocuphire Pharma
Results
October 2022
topical eyedrops in clinical development for | Ocuphire Pharma
Recursion Pharmaceuticals
Investor Day
January 2023
clinical dosage hypothesis rescue of may impact tumor progression and or restore sensitivity in cancers driven by loss recursion differentiation rescues tumor suppressor genes and and are negative regulators of signaling both proteins form part of the destruction complex strong clustering suggests map recapitulation of this biology insight from novel insight around established | Recursion Pharmaceuticals
Search Thousands of Presentations by World Leading Companies
Trending:
Addressable Market
Ecosystem
Beauty Market
WACC
NFT
Management Team
Investment Highlights

Stay in the loop

Join our mailing list to stay in the loop with updates and newest feature releases

Presentations

Start Up
IPO
SPAC
M&A
Investor Day
Results
ESG
Credit
Investment Banking

Explore

Presentation Collections
Slide Collections

Company

Blog
Contact us
© 2021-2023 Slidebook.io